» Articles » PMID: 24954725

Effect of Liquid Crystals with Cyclodextrin on the Bioavailability of a Poorly Water-soluble Compound, Diosgenin, After Its Oral Administration to Rats

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2014 Jun 24
PMID 24954725
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Diosgenin, found in wild yam (Dioscorea villosa), has been shown to ameliorate diabetes and hyperlipidemia, increase cell proliferation in a human 3D skin model, and inhibits melanin production in B16 melanoma cells. It is also an active element in cosmeceutical and dietary supplements. Although the bioavailability of diosgenin is low due to its poor solubility and intestinal permeability, it was subsequently improved using a β-cyclodextrin (β-CD) inclusion complex. Recently liquid crystals (LCs) were shown to enhance the bioavailability of poorly water-soluble drugs. The purpose in the present study was to prepare diosgenin LCs and investigate the interaction between LC and β-CD in order to improve its bioavailability of diosgenin. Crystallinity and particle diameters of LCs in water were determined by small angle X-ray scattering (SAXS) and Zetasizer. Pharmacokinetic parameters were calculated using the plasma content of diosgenin after its oral administration to Wistar rats. Regarding the formation of glyceryl monooleate (GMO) and phytantriol (PHY) LC, SAXS patterns showed the hexagonal and cubic phases, respectively. Bioavailability was significantly enhanced after oral administration of LCs prepared by GMO than after diosgenin alone. The bioavailability was further improved with the combination of LC and β-CD than LC and water.

Citing Articles

Steroidal Saponins: Naturally Occurring Compounds as Inhibitors of the Hallmarks of Cancer.

Bouabdallah S, Al-Maktoum A, Amin A Cancers (Basel). 2023; 15(15).

PMID: 37568716 PMC: 10417465. DOI: 10.3390/cancers15153900.


Natural drugs targeting inflammation pathways can be used to treat atherosclerosis.

Song X, Wang X, Wang D, Zheng Z, Li J, Li Y Front Pharmacol. 2022; 13:998944.

PMID: 36386165 PMC: 9663817. DOI: 10.3389/fphar.2022.998944.


Pharmacokinetic Analysis of Diosgenin in Rat Plasma by a UPLC-MS/MS Approach.

Liu P, Xu L, Guo J, Chang J, Liu X, Xue H J Anal Methods Chem. 2022; 2022:5607347.

PMID: 36248054 PMC: 9553667. DOI: 10.1155/2022/5607347.


Identification of the Natural Steroid Sapogenin Diosgenin as a Direct Dual-Specific RORα/γ Inverse Agonist.

Schwarz P, Perhal A, Schoberl L, Kraus M, Kirchmair J, Dirsch V Biomedicines. 2022; 10(9).

PMID: 36140177 PMC: 9495423. DOI: 10.3390/biomedicines10092076.


Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis.

Wang D, Wang X Drug Des Devel Ther. 2022; 16:2305-2323.

PMID: 35875677 PMC: 9304635. DOI: 10.2147/DDDT.S368836.